A bottle of Bayer AG Roundup brand weedkiller is arranged for a photograph in a garden shed in Princeton, Illinois, U.S., on Thursday, March 28, 2019. Bayer vowed to keep defending its weedkiller Roundup after losing a second trial over claims it causes cancer, indicating that the embattled company isn't yet ready to consider spending billions of dollars to settle thousands of similar lawsuits. Photographer: Daniel Acker/Bloomberg
Bayer has petitioned a California appeals court to reverse a jury's $2 billion verdict over Roundup, insisting that "egregious and pervasive misconduct" by plaintiffs counsel infected the trial.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Amanda Bronstad
Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Law.com Class Actions: Critical Mass. She is based in Los Angeles.
